Home » Newsletters » BioWorld Science

BioWorld Science

April 26, 2011

View Archived Issues

Delcasertib does not benefit patients with heart damage from reperfusion injury

New CSF-1-R inhibitor DCC-2909 shows promise to treat bone metastasis

In vivo data support evaluation of XP-23829 for treatment of RRMS

Phase II AMG-785 trial in postmenopausal osteoporosis meets primary endpoint

Gilead and MicroDose Therapeutx to develop MDT-637 for treatment of RSV infection

Low levels of dickkopf-related protein 3 may predict poor outcome in cervical cancer

KW-2450 suppresses tumor growth in vivo and advances in phase I/II trial in breast cancer

Glycoengineered CIFN derivatives display improved pharmacokinetics

Zhejiang Beta Pharma presents new protein kinase inhibitors for cancer

Novel FADK 1 inhibitors described by Boehringer Ingelheim

Novartis and Xenon Pharma design new acyl-CoA desaturase inhibitors

New inhibitors of leucine-rich repeat serine/threonine-protein kinase 2 claimed

U.S. researchers present novel Bcl-2 inhibitors for cancer

Clinuvel and EMA to meet regarding proposed MAA for Scenesse in EPP

Prana Biotechnology accelerates development of PBT-2

Hanmi Pharmaceuticals to acquire rights for KX-01 in selected Asian territories

Aduro BioTech raises funds to support development of CRS-207 and other vaccines

Spectrum Pharma receives FDA approval for ready-to-use formulation of Fusilev

Advanced Cell Technology seeks clearance for phase I/II retinal pigment epithelial cell trial

NanoBio gains rights to antigen for prevention of urinary tract infections

FDA orphan designation for NKTR-102 in ovarian cancer

CytRx expands enrollment in phase IIb tamibarotene trial in NSCLC

Daiichi Sankyo's Lixiana receives first approval in Japan

Halaven approved in Japan for inoperable and recurrent breast cancer

Mircera approved in Japan for renal anemia

Merrimack Pharma begins phase I MM-111 combination trial in solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...